Comparing COVID-19-related hospitalization rates among individuals with infection-induced and vaccine-induced immunity in Israel
With the COVID-19 pandemic ongoing, accurate assessment of population immunity and the effectiveness of booster and enhancer vaccine doses is critical. We compare COVID-19-related hospitalization incidence rates in 2,412,755 individuals across four exposure levels: non-recent vaccine immunity (two B...
Main Authors: | Balicer, R.D (Author), Barda, N. (Author), Dagan, N. (Author), Makov-Assif, M. (Author), Netzer, D. (Author), Reis, B.Y (Author), Waxman, J.G (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Research
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Effectiveness of BNT162b2 COVID-19 Vaccine in Preventing Severe Symptomatic Infection among Healthcare Workers
by: Efrén Murillo-Zamora, et al.
Published: (2021-07-01) -
Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI)
by: Akriv, A., et al.
Published: (2022) -
Heterologous ChAdOx1 nCoV-19/BNT162b2 Prime-Boost Vaccination Induces Strong Humoral Responses among Health Care Workers
by: Louise Benning, et al.
Published: (2021-08-01) -
SARS-CoV-2 anti-spike antibody titres after vaccination with BNT162b2 in naïve and previously infected individuals
by: Andrea Lombardi, et al.
Published: (2021-08-01) -
A novel adverse effect of the BNT162b2 mRNA vaccine: First episode of acute mania with psychotic features
by: Umit Haluk Yesilkaya, et al.
Published: (2021-12-01)